Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04131946 · ClinicalTrials.gov registry record · NA

Cancer Screening; Access; Awareness; Navigation

A NA study of Colorectal Cancer Screening, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
37
Enrollment target
2
Study locations

NCT04131946 is a NA study of Colorectal Cancer Screening that has completed, run by University of Illinois at Chicago. The registered enrollment target is 37 participants, below the 5,881-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04131946, a NA study of Colorectal Cancer Screening, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
2
Study locations

Study Summary

To assess the feasibility and efficacy of community-based Colorectal Cancer (CRC) screening intervention in increasing CRC screening rates To evaluate individual-level knowledge related to CRC screening and risk factors To characterize individual -level facilitators and barriers to engaging in CRC screening and related diagnostic tests and treatment when applicable.

Interventions

  • OTHER Community-Based (Intervention Arm)

Study Locations (2)

Illinois

  • University of Illinois - Chicago
  • Mile Square Health Center - Englewood - Chicago

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2019-11-12
Est. Completion 2021-12-20
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT04131946

The ClinicalTrials.gov registry entry for NCT04131946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,881-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which Community-Based (Intervention Arm) is the first listed.

NCT04131946 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04131946 about?

NCT04131946 is a clinical study titled "Cancer Screening; Access; Awareness; Navigation". To assess the feasibility and efficacy of community-based Colorectal Cancer (CRC) screening intervention in increasing CRC screening rates To evaluate individual-level knowledge related to CRC screening and risk factors To characterize individual -level facilitators and barriers to engaging in CRC s...

What is the current status of trial NCT04131946?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2019-11-12. Estimated completion is 2021-12-20.

What conditions does trial NCT04131946 study?

This clinical trial studies the following conditions: Colorectal Cancer Screening.

What interventions are being tested in trial NCT04131946?

The interventions under investigation include: Community-Based (Intervention Arm) (OTHER).

Who is sponsoring clinical trial NCT04131946?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04131946 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.